Ma-Spore ALL 2020 Study

Conditions: B Lymphoblastic Leukemia Interventions: Drug: Prednisolone; Drug: Dexamethasone; Drug: Vincristine; Drug: Methotrexate; Drug: L-Asparaginase; Drug: Pegylated asparaginase; Drug: Erwinase; Drug: Dasatinib; Drug: Imatinib; Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Mercaptopurine; Drug: Thioguanine; Drug: Rituximab; Drug: Doxorubicin; Drug: Fludarabine Sponsors: National University Hospital, Singapore Recruiting

https://clinicaltrials.gov/study/NCT06336395

Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials